Literature DB >> 3399823

Epidemiology of ulcerative colitis in western Norway.

K Haug1, E Schrumpf, S Barstad, G Fluge, J F Halvorsen.   

Abstract

The incidence of ulcerative colitis (UC) in the three counties that compose Western Norway was registered in a prospective study during the years 1984 and 1985. Both inpatients and outpatients were included. Five hundred and fifty general practitioners and 12 hospitals participated in the study. A total of 239 patients were diagnosed in this area with 807,000 inhabitants, giving a mean annual incidence of 14.8 per 100,000. For patients between 30 and 35 years of age the age-specific incidence rate was 31.2. The M/F sex ratio was 1.10. Familial occurrence of inflammatory bowel disease was found in 11% of the patients. Patients with rectal involvement only constituted 35% of the patients.

Entities:  

Mesh:

Year:  1988        PMID: 3399823     DOI: 10.3109/00365528809093904

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway.

Authors:  B Moum; A Ekbom; M H Vatn; E Aadland; J Sauar; I Lygren; T Schulz; N Stray; O Fausa
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 2.  Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?

Authors:  Cristina Saro Gismera; Beatriz Sicilia Aladrén
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

3.  Ulcerative proctitis in central Sweden 1965-1983. A population-based epidemiological study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

4.  Altered expression of mucins throughout the colon in ulcerative colitis.

Authors:  J E Smithson; A Campbell; J M Andrews; J D Milton; R Pigott; D P Jewell
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

5.  Ulcerative colitis in a multiracial Asian country: racial differences and clinical presentation among Malaysian patients.

Authors:  Yan-Mei Tan; Khean-Lee Goh
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

6.  Gene and cell therapy based treatment strategies for inflammatory bowel diseases.

Authors:  Sander van der Marel; Anna Majowicz; Sander van Deventer; Harald Petry; Daniel W Hommes; Valerie Ferreira
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

Review 7.  Oral bile acids in cystic fibrosis-associated liver disease.

Authors:  C Colombo; A Crosignani; M G Apostolo; M T Marzano; N Bettinardi; A Giunta
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

8.  Acute and chronic gastrointestinal manifestations associated with Yersinia enterocolitica infection. A Norwegian 10-year follow-up study on 458 hospitalized patients.

Authors:  A Saebø; J Lassen
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

Review 9.  Current global trends in the incidence of pediatric-onset inflammatory bowel disease.

Authors:  Josef Sýkora; Renáta Pomahačová; Marcela Kreslová; Dominika Cvalínová; Přemysl Štych; Jan Schwarz
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.